{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:03:51Z","timestamp":1791133431142,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Science and Technology Program of Sichuan","award":["2024YFFK0214, 2024NSFSC1690 and 2022NSFSC1559"],"award-info":[{"award-number":["2024YFFK0214, 2024NSFSC1690 and 2022NSFSC1559"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04198-4","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:56:55Z","timestamp":1772193415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tissue-derived extracellular vesicles\u2013mediated delivery of a hepatic enzyme living panorama (HELP) for treating multifactorial liver diseases"],"prefix":"10.1186","volume":"24","author":[{"given":"Xin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fudong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangneng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"12","key":"4198_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.tips.2021.09.004","volume":"42","author":"DR Davydov","year":"2021","unstructured":"Davydov DR, Prasad B. Assembling the P450 puzzle: on the sources of nonadditivity in drug metabolism. Trends Pharmacol Sci. 2021;42(12):988\u201397. https:\/\/doi.org\/10.1016\/j.tips.2021.09.004.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"4198_CR2","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/nrd1851","volume":"4","author":"LC Wienkers","year":"2005","unstructured":"Wienkers LC, Heath TG. Predicting in vivo drug interactions from in vitro drug discovery data. Nat Rev Drug Discov. 2005;4(10):825\u201333. https:\/\/doi.org\/10.1038\/nrd1851.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4198_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tips.2023.11.001","volume":"45","author":"B Dudas","year":"2024","unstructured":"Dudas B, Miteva MA. Computational and artificial intelligence-based approaches for drug metabolism and transport prediction. Trends Pharmacol Sci. 2024;45(1):39\u201355. https:\/\/doi.org\/10.1016\/j.tips.2023.11.001.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"4198_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1124\/pharmrev.122.000810","volume":"75","author":"W Sadee","year":"2023","unstructured":"Sadee W, Wang D, Hartmann K, Toland AE. Pharmacogenomics: driving personalized medicine. Pharmacol Rev. 2023;75(4):789\u2013814. https:\/\/doi.org\/10.1124\/pharmrev.122.000810.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"4198_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.12.007.","journal-title":"Pharmacol Ther"},{"key":"4198_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.03.006","volume":"86","author":"N Ai","year":"2015","unstructured":"Ai N, Fan X, Ekins S. In Silico methods for predicting drug-drug interactions with cytochrome P-450s, transporters and beyond. Adv Drug Deliv Rev. 2015;86:46\u201360. https:\/\/doi.org\/10.1016\/j.addr.2015.03.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"4198_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fphar.2016.00388","volume":"7","author":"R Fujiwara","year":"2016","unstructured":"Fujiwara R, Yokoi T, Nakajima M. Structure and Protein-Protein interactions of human UDP-Glucuronosyltransferases. Front Pharmacol. 2016;7:388. https:\/\/doi.org\/10.3389\/fphar.2016.00388. Published 2016 Oct 24.","journal-title":"Front Pharmacol"},{"issue":"23","key":"4198_CR8","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1042\/BCJ20190532","volume":"476","author":"NY Davydova","year":"2019","unstructured":"Davydova NY, Dangi B, Maldonado MA, Vavilov NE, Zgoda VG, Davydov DR. Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2. Biochem J. 2019;476(23):3661\u201385. https:\/\/doi.org\/10.1042\/BCJ20190532.","journal-title":"Biochem J"},{"issue":"3","key":"4198_CR9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/15592294.2020.1795601","volume":"16","author":"F Shafiee-Kermani","year":"2021","unstructured":"Shafiee-Kermani F, Carney ST, Jima D, et al. Expression of UDP glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells. Epigenetics. 2021;16(3):289\u201399. https:\/\/doi.org\/10.1080\/15592294.2020.1795601.","journal-title":"Epigenetics"},{"key":"4198_CR10","doi-asserted-by":"publisher","first-page":"100030","DOI":"10.1074\/jbc.RA120.015911","volume":"296","author":"JP Connick","year":"2021","unstructured":"Connick JP, Reed JR, Cawley GF, Backes WL. Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: interactions between CYP1A2 and Heme oxygenase-1. J Biol Chem. 2021;296:100030. https:\/\/doi.org\/10.1074\/jbc.RA120.015911.","journal-title":"J Biol Chem"},{"key":"4198_CR11","doi-asserted-by":"publisher","unstructured":"Hu JJ, Pan CG, Xu XR, et al. Cytochrome P450-mediated biotransformation of octocrylene in tetradesmus obliquus: integrative insights from transcriptomics, proteomics, molecular docking, and density functional theory calculation. J Hazard Mater Published Online August. 2025;10. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.139512.","DOI":"10.1016\/j.jhazmat.2025.139512"},{"key":"4198_CR12","doi-asserted-by":"publisher","unstructured":"Peng Z, Wang J, Gu J, Yang X, Wang P, Deng J. Stepwise degradation of bisphenol A into various monocyclic aromatic hydrocarbons by a P450 enzyme BisdB in Sphingobium Yanoikuyae GDP. J Hazard Mater Published Online August. 2025;16. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.139582.","DOI":"10.1016\/j.jhazmat.2025.139582"},{"issue":"1","key":"4198_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2022.08.018","volume":"13","author":"S Marie","year":"2023","unstructured":"Marie S, Frost KL, Hau RK, et al. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients. Acta Pharm Sin B. 2023;13(1):1\u201328. https:\/\/doi.org\/10.1016\/j.apsb.2022.08.018.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"4198_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1124\/pharmrev.120.000071","volume":"73","author":"BD van Groen","year":"2021","unstructured":"van Groen BD, Nicola\u00ef J, Kuik AC, et al. Ontogeny of hepatic transporters and Drug-Metabolizing enzymes in humans and in nonclinical species. Pharmacol Rev. 2021;73(2):597\u2013678. https:\/\/doi.org\/10.1124\/pharmrev.120.000071.","journal-title":"Pharmacol Rev"},{"key":"4198_CR15","doi-asserted-by":"publisher","first-page":"118155","DOI":"10.1016\/j.biopha.2025.118155","volume":"187","author":"K Kosicka-Noworzy\u0144","year":"2025","unstructured":"Kosicka-Noworzy\u0144 K, Romaniuk-Drapa\u0142a A, Sheng YH, Yohn C, Brunetti L, Kagan L. Obesity-related drug-metabolizing enzyme expression alterations in the human liver. Biomed Pharmacother. 2025;187:118155. https:\/\/doi.org\/10.1016\/j.biopha.2025.118155.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4198_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/cpt.3643","volume":"118","author":"LWT Tang","year":"2025","unstructured":"Tang LWT, Varma MVS. Hepatic impairment and the differential effects on drug clearance mechanisms: analysis of Pharmacokinetic changes in disease state. Clin Pharmacol Ther. 2025;118(3):673\u201381. https:\/\/doi.org\/10.1002\/cpt.3643.","journal-title":"Clin Pharmacol Ther"},{"key":"4198_CR17","doi-asserted-by":"publisher","first-page":"119142","DOI":"10.1016\/j.jep.2024.119142","volume":"339","author":"I Husain","year":"2025","unstructured":"Husain I, Abdulrahman B, Dale OR, et al. Interaction of phyllanthus Amarus extract and its lignans with human xenobiotic receptors, drug metabolizing enzymes and drug transporters. J Ethnopharmacol. 2025;339:119142. https:\/\/doi.org\/10.1016\/j.jep.2024.119142.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"4198_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41392-025-02312-w","volume":"10","author":"G Xu","year":"2025","unstructured":"Xu G, Jin J, Fu Z, et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther. 2025;10(1):255. https:\/\/doi.org\/10.1038\/s41392-025-02312-w. Published 2025 Aug 14.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4198_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12951-025-03602-9","volume":"23","author":"KM Tembo","year":"2025","unstructured":"Tembo KM, Wang X, Bolideei M, et al. Exploring the bioactivity of MicroRNAs originated from Plant-derived Exosome-like nanoparticles (PELNs): current perspectives. J Nanobiotechnol. 2025;23(1):563. https:\/\/doi.org\/10.1186\/s12951-025-03602-9. Published 2025 Aug 12.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"4198_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","volume":"16","author":"IK Herrmann","year":"2021","unstructured":"Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748\u201359. https:\/\/doi.org\/10.1038\/s41565-021-00931-2.","journal-title":"Nat Nanotechnol"},{"issue":"492","key":"4198_CR21","doi-asserted-by":"publisher","first-page":"eaav8521","DOI":"10.1126\/scitranslmed.aav8521","volume":"11","author":"OPB Wiklander","year":"2019","unstructured":"Wiklander OPB, Brennan M\u00c1, L\u00f6tvall J, Breakefield XO, El Andaloussi S. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. 2019;11(492):eaav8521. https:\/\/doi.org\/10.1126\/scitranslmed.aav8521.","journal-title":"Sci Transl Med"},{"key":"4198_CR22","doi-asserted-by":"publisher","unstructured":"Morales-Kastresana A, Musich TA, Welsh JA et al. High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer. J Extracell Vesicles. 2019;8(1):1597603. Published 2019 Jun 19. https:\/\/doi.org\/10.1080\/20013078.2019.1597603","DOI":"10.1080\/20013078.2019.1597603"},{"issue":"4","key":"4198_CR23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","volume":"165","author":"JJ Wattacheril","year":"2023","unstructured":"Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ. AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review. Gastroenterology. 2023;165(4):1080\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2023.06.013.","journal-title":"Gastroenterology"},{"issue":"5","key":"4198_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","volume":"18","author":"D Wang","year":"2019","unstructured":"Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov. 2019;18(5):358\u201378. https:\/\/doi.org\/10.1038\/s41573-019-0012-9.","journal-title":"Nat Rev Drug Discov"},{"key":"4198_CR25","doi-asserted-by":"publisher","first-page":"33641","DOI":"10.1038\/srep33641","volume":"6","author":"A G\u00e1mez-Valero","year":"2016","unstructured":"G\u00e1mez-Valero A, Mongui\u00f3-Tortajada M, Carreras-Planella L, Franquesa Ml, Beyer K, Borr\u00e0s FE. Size-Exclusion Chromatography-based isolation minimally alters extracellular vesicles\u2019 characteristics compared to precipitating agents. Sci Rep. 2016;6:33641. https:\/\/doi.org\/10.1038\/srep33641. Published 2016 Sep 19.","journal-title":"Sci Rep"},{"issue":"4","key":"4198_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.30651","volume":"70","author":"HL Paish","year":"2019","unstructured":"Paish HL, Reed LH, Brown H, et al. A bioreactor technology for modeling fibrosis in human and rodent Precision-Cut liver slices. Hepatology. 2019;70(4):1377\u201391. https:\/\/doi.org\/10.1002\/hep.30651.","journal-title":"Hepatology"},{"issue":"9","key":"4198_CR27","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/nprot.2010.111","volume":"5","author":"IA de Graaf","year":"2010","unstructured":"de Graaf IA, Olinga P, de Jager MH, et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc. 2010;5(9):1540\u201351. https:\/\/doi.org\/10.1038\/nprot.2010.111.","journal-title":"Nat Protoc"},{"issue":"1","key":"4198_CR28","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750. Published 2018 Nov 23.","journal-title":"J Extracell Vesicles"},{"key":"4198_CR29","doi-asserted-by":"publisher","unstructured":"Rungratanawanich W, Qu Y, Holmes A, Kaplowitz N, Song BJ. Early oxidative protein modifications and gut damage\/leakiness contribute to drug-induced acute liver failure. Clin Mol Hepatol Published Online August. 2025;4. https:\/\/doi.org\/10.3350\/cmh.2025.0748.","DOI":"10.3350\/cmh.2025.0748"},{"issue":"1","key":"4198_CR30","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1038\/s41467-025-63212-9","volume":"16","author":"J Gu","year":"2025","unstructured":"Gu J, Lao L, Hu L, et al., et al. Nascent liver proteome reveals enzymes and transcription regulators under physiological and alcohol exposure conditions. Nat Commun. 2025;16(1):7945. https:\/\/doi.org\/10.1038\/s41467-025-63212-9. Published 2025 Aug 26.","journal-title":"Nat Commun"},{"issue":"2","key":"4198_CR31","doi-asserted-by":"publisher","first-page":"e16234","DOI":"10.1111\/liv.16234","volume":"45","author":"X Zeng","year":"2025","unstructured":"Zeng X, Wu T, Xu Q, et al. Inhibition of IRE-1\u03b1 alleviates pyroptosis and metabolic Dysfunction-Associated steatohepatitis by suppressing gasdermin D. Liver Int. 2025;45(2):e16234. https:\/\/doi.org\/10.1111\/liv.16234.","journal-title":"Liver Int"},{"issue":"1","key":"4198_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"},{"key":"4198_CR33","doi-asserted-by":"publisher","unstructured":"Zhang N, Zhang X, Yan T, et al. Extrachromosomal DNA (ecDNA) drives hepatocellular carcinoma malignancy through high-copy amplification of chromosome 1q21-derived PIP5K1A oncogene. Cancer Lett Published Online August. 2025;25. https:\/\/doi.org\/10.1016\/j.canlet.2025.218004.","DOI":"10.1016\/j.canlet.2025.218004"},{"issue":"3","key":"4198_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/HEP.0000000000001454","volume":"82","author":"RM Wilechansky","year":"2025","unstructured":"Wilechansky RM. Surging sludge: intrahepatic cholangiocarcinoma mortality on the rise worldwide. Hepatology. 2025;82(3):543\u20134. https:\/\/doi.org\/10.1097\/HEP.0000000000001454.","journal-title":"Hepatology"},{"key":"4198_CR35","doi-asserted-by":"publisher","unstructured":"Blair AB, Alobuia WM, Palta M, et al. Locoregional treatment options for locally advanced intrahepatic cholangiocarcinoma. J Natl Compr Canc Netw Published Online August. 2025;14. https:\/\/doi.org\/10.6004\/jnccn.2025.7085.","DOI":"10.6004\/jnccn.2025.7085"},{"key":"4198_CR36","doi-asserted-by":"publisher","unstructured":"McGrath KE, Olsen JL, Koniski AD et al. BMI1 regulates human erythroid self-renewal through both gene repression and gene activation. Nat Commun. 2025;16(1):7619. Published 2025 Aug 15. https:\/\/doi.org\/10.1038\/s41467-025-62993-3","DOI":"10.1038\/s41467-025-62993-3"},{"key":"4198_CR37","doi-asserted-by":"publisher","first-page":"108075","DOI":"10.1016\/j.biotechadv.2022.108075","volume":"62","author":"HM Zabed","year":"2023","unstructured":"Zabed HM, Akter S, Rupani PF, et al. Biocatalytic gateway to convert glycerol into 3-hydroxypropionic acid in waste-based biorefineries: Fundamentals, limitations, and potential research strategies. Biotechnol Adv. 2023;62:108075. https:\/\/doi.org\/10.1016\/j.biotechadv.2022.108075.","journal-title":"Biotechnol Adv"},{"issue":"1","key":"4198_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40168-017-0286-2","volume":"5","author":"S Namasivayam","year":"2017","unstructured":"Namasivayam S, Maiga M, Yuan W, et al. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome. 2017;5(1):71. https:\/\/doi.org\/10.1186\/s40168-017-0286-2. Published 2017 Jul 7.","journal-title":"Microbiome"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04198-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:51:44Z","timestamp":1775220704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4198"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04198-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were approved by the Institutional Animal Care and Use Committee of Sichuan University (Approval No. 2018010 A). The use of human liver tissues was reviewed and approved by the West China Hospital Ethics Committee (Approval No. WCH20180037). All participants provided written informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}